The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection.

Hepatitis C virus (HCV) readily sets up a persistent infection and is a major cause of liver disease worldwide. Interferon alfa and ribavirin therapy lead to sustained clearance of virus in 31% to 64% of patients with type 1 and non-type 1 genotypes, respectively. It is not clear to what extent thes...

Full description

Bibliographic Details
Main Authors: Barnes, E, Harcourt, G, Brown, D, Lucas, M, Phillips, R, Dusheiko, G, Klenerman, P
Format: Journal article
Language:English
Published: 2002